Evaluate the Immunogenicity of a Novel Glucagon Formulation

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by AMG Medical Inc.
Sponsor:
Information provided by (Responsible Party):
AMG Medical Inc.
ClinicalTrials.gov Identifier:
NCT01959334
First received: October 5, 2013
Last updated: October 8, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)